• Results
  • Progress analysis: Is the industry doing more to improve access...
Progress analysis

Is the industry doing more to improve access to medicine?

The analysis presented here is based on the comparison of the 2021 Index main findings with the 2018 Index and the 10-year analysis report to assess progress made by the industry. Although the methodology has been updated with a new robust framework since 2018, viable comparisons have been drawn in the core technical areas assessed by the Index to drive action in the industry.

Explore further

How we measure

How we measure

The Index evaluates pharmaceutical companies in areas where they have the biggest potential and responsibility to make change, such as R&D and pricing. Find out more about the analytical framework and areas of evaluation.

Get in touch

Back to top |